Welcome To The Oncolytics Biotech HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
AGORACOM NEWS FLASH

BREAKING: Esports Entertainment Group Signs Definitive Agreement to Acquire Online Sportsbook and Casino Operator Argyll Entertainment

  • Signed a definitive agreement to acquire holding company of online sportsbook and casino operator Argyll Entertainment AG and its operating subsidiaries
  • Closing of the acquisition is expected to occur on or before July 31, 2020
  • “As a fast growing and innovative online gaming company licensed in the UK and Ireland, Argyll offers Esports Entertainment Group access to exclusive and proprietary sports and gaming content, including the flagship SportNation.bet brand and an award-winning rewards program, which was a major driver of Argyll’s $12 million in revenue in 2019,”

Eeg logo black 01

Hub On AGORACOM / Read Release

Message: Recent Comments

Via The Life Science Report:

Expert Comments:

Alan Ridgeway, Paradigm Capital (10/1/13) "Oncolytics Biotech Inc. is well positioned as the market leader in virus-medicated cancer therapy; its lead product, REOLYSIN, has produced impressive clinical results to date in multiple indications and has the potential to revolutionize the treatment of cancer. We believe a number of catalysts will occur in the next three months: 1) survival data from its phase 3 trial in head and neck cancer; 2) the release of mature lung cancer data from 2 separate phase 2a trials; and 3) potential releases of data from randomized trials in pancreatic and ovarian cancer."

Share
New Message
Please login to post a reply